[1] Cui, Y.; Han, J. A proposed definition of rare diseases for China: from the perspective of return on investment in new orphan drugs. Orphanet. J. Rare Dis. 2015, 10, 28.
[2] The 107th Congress United States Congress. Rare Disease Act of 2002. https://www.govtrack.us/congress/bills/107/hr4013 (accessed March 18, 2017)
[3] European Parliament. Regulation (EC) No. 1901/2006 on medicinal products for paediatric use and amending. http://www.wipo.int/wipolex/en/details.jsp?id=5940b (accessed March 18, 2017)
[4] Hayashi, S.; Umeda, T. 35 years of Japanese policy on rare diseases. Lancet. 2008, 372, 889-890.
[5] Song, P.; Gao, J.; Inagaki, Y.; Kokudo, N.; Tang, W. Rare diseases, orphan drugs, and their regulation in Asia: Current status and future perspectives. Intractable Rare Dis. Res. 2012, 1, 3-9.
[6] Achelrod, D.; Blankart, C.R.; Linder, R.; von Kodolitsch, Y.; Stargardt, T. The economic impact of Marfan syndrome: a non-experimental, retrospective, population-based matched cohort study. Orphanet. J. Rare Dis. 2014, 9, 90.
[7] Kanters, T.A.; de Sonneville-Koedoot, C.; Redekop, W.K.; Hakkaart, L. Systematic review of available evidence on 11 high-priced inpatient orphan drugs. Orphanet. J. Rare Dis. 2013, 8, 124.
[8] Kevany, S.; Murima, O.; Singh, B.; Hlubinka, D.; Kullch, M.; Morin, S.F.; Sweat, M. Socio-economic status and health care utilisation in rural Zimbabwe: findings from Project Accept (HPTN 043). J. Public Health Africa. 2012, 3, 46-51.
[9] Aygoren-Pursun, E.; Bygum, A.; Beusterien, K.; Hautamaki, E.; Sisic, Z.; Wait, S.; Boysen, H.B.; Caballero, T. Socioeconomic burden of hereditary angioedema: results from the hereditary angioedema burden of illness study in Europe. Orphanet J. Rare Dis. 2014, 9, 99.
[10] Henrard, S.; Devleesschauwer, B.; Beutels, P.; Callens, M.; De Smet, F.; Hermans, C.; Speybroeck, N. The health and economic burden of haemophilia in Belgium: a rare, expensive and challenging disease. Orphanet. J. Rare Dis. 2014, 9, 39.
[11] Hime, N.J.; Fitzgerald, D.; Robinson, P.; Selvadurai, H.; Van, A.P.; Jaffé, A.; Zurynski, Y. Childhood interstitial lung disease due to surfactant protein C deficiency: frequent use and costs of hospital services for a single case in Australia. Orphanet. J. Rare Dis. 2014, 9, 36.
[12] Weinreb, N.J.; Finegold, D.N.; Feingold, E.; Zeng, Z.; Rosenbloom, B.E.; Shankar, S.P.; Amato, D. Evaluation of disease burden and response to treatment in adults with type 1 gaucher disease using a validated disease severity scoring system (DS3). Orphanet. J. Rare Dis. 2015, 10, 64.
[13] Rollet, P.; Lemoine, A.; Dunoyer, M. Sustainable rare diseases business and drug access: no time for misconceptions. Orphanet. J. Rare Dis. 2013, 8, 109.
[14] Polistena, B.; Spandonaro, F.; Zocchetti, C.; Daina, E. Epidemiology and Healthcare Services Utilisation for Rare Diseases in Italy. Value Health. 2015, 18, A681.
[15] Angelis, A.; Tordrup, D.; Kanavos, P. Socio-economic burden of rare diseases: A systematic review of cost of illness evidence. Health Policy. 2015, 119, 964-979.
[16] Giunti, P.; Greenfield, J.; Stevenson, A.J.; Parkinson, M.H.; Hartmann, J.L.; Sandtmann, R.; Piercy, J.; O’Hara, J.; Casas, L.R.; Smith, F.M. Impact of Friedreich’s Ataxia on health-care resource utilisation in the United Kingdom and Germany. Orphanet. J. Rare Dis. 2013, 8, 38.
[17] Johansen, H.; Andresen, I.L.; Naess, E.E.; Hagen, K.B. Health status of adults with Short Stature: A comparison with the normal population and one well-known chronic disease (Rheumatoid Arthritis). Orphanet J. Rare Dis. 2007, 2, 10.
[18] Benyamini, Y.; Boyko, V.; Blumstein, T.; Lerner-Geva, L. Health, cultural and socioeconomic factors related to self-rated health of long-term Jewish residents, immigrants, and Arab women in midlife in Israel. Women Health. 2014, 54, 402-424.
[19] Mudde, C. Racist Extremism in Central and Eastern Europe. East Europ. Politics Societies. 2005, 19, 161-184.
[20] Ohara, Y.; Hirano, H.; Watanabe, Y.; Obuchi, S.; Yoshida, H.; Fujiwara, Y.; Ihara, K.; Kawai, H.; Mataki, S. Factors associated with self-rated oral health among community-dwelling older Japanese: A cross-sectional study. Geriatr. Gerontol. Int. 2015, 15, 755-761.
[21] Chen, Y.; While, A.E.; Hicks, A. Self-rated health and associated factors among older people living alone in Shanghai. Geriatr. Gerontol. Int. 2015, 15, 457-464.
[22] Xin, X.X.; Guan, X.D.; Shi, L.W. Catastrophic expenditure and impoverishment of patients affected by 7 rare diseases in China. Orphanet. J. Rare Dis. 2016, 11, 74.
[23] Greek-Winald, C.; Gustafsson, B.; Hogvik, L. The Swedish rare disease information database and the Swedish information centre for rare diseases. Orphanet. J. Rare Dis. 2010, 5, O27.
[24] Nicolas, A.; Lucchetti-Miganeh, C.; Yaou, R.B.; Kaplan, J.C.; Chelly, J.; Leturcq, F.; Barloy-Hubler, F.; Le Rumeur, E. Assessment of the structural and functional impact of in-frame mutations of the DMD gene, using the tools included in the eDystrophin online database. Orphanet. J. Rare Dis. 2012, 7, 45.
[25] Fusco, F.; Paciolla, M.; Conte, M.I.; Pescatore, A.; Esposito, E.; Mirabelli, P.; Lioi, M.B.; Ursini, M.V. Incontinentia pigmenti: report on data from 2000 to 2013. Orphanet. J. Rare Dis. 2014, 9, 93.
[26] Trocello, J. Wilson France: a national database for Wilson’s disease. Orphanet. J. Rare Dis. 2010, 5, 21.
[27] Perehudoff, K.; Toebes, B.; Hogerzeil, H. A human rights-based approach to the reimbursement of expensive medicines. Bull. World Health Organ. 2016, 94, 935-936.
[28] Napoles, A.M.; Ortíz, C.; O’Brien, H.; Sereno, A.B.; Kaplan, C.P. Coping resources and self-rated health among Latina breast cancer survivors. Oncol. Nurs. Forum. 2011, 38, 523-531.
[29] Eng, J.A.; Clough-Gorr, K.; Cabral, H.J.; Silliman, R.A. Predicting 5- and 10-year survival in older women with early-stage breast cancer: self-rated health and walking ability. J. Am. Geriatr. Soc. 2015, 63, 757-762.
[30] Ortiz-Agapito, F.; Colmenares-Bonilla, D. Quality of life of patients with fibrodysplasia ossificans progressiva. J. Child. Orthop. 2015, 9, 489-493.
[31] Moor, I.; Spallek, J.; Richter, M. Explaining socioeconomic inequalities in self-rated health: a systematic review of the relative contribution of material, psychosocial and behavioural factors. J. Epidemiol. Community Health. 2017, 71, 565-575.
[32] Pogany, G. The present situation of Central/Eastern Europe? The role of patient Orphanet. J. Rare Dis. 2010, 5, O30. |